1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Aphasia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Aphasia Clinical Trials by Region
2.2.2 Average Enrollment of Aphasia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Aphasia Treatment, 2019

3. Region wise Aphasia Clinical Trials
3.1 Asia Pacific Aphasia Clinical Trials by Country
3.2 Europe Aphasia Clinical Trials by Country
3.3 North America Aphasia Clinical Trials by Country
3.4 Middle East and Africa Aphasia Clinical Trials by Country
3.5 South and Central America Aphasia Clinical Trials by Country

4. Aphasia Clinical Trial Trends
4.1 Start Year wise Aphasia Clinical Trials
4.2 Phase wise Aphasia Clinical Trials
4.3 Trial Status wise Aphasia Clinical Trials
4.4 Trial Type wise Aphasia Clinical Trials

5. Aphasia Average Enrollment Trends
5.1 Average Enrollment in Aphasia Trials by Year
5.2 Average Enrollment in Aphasia Trials by Phase
5.3 Average Enrollment in Aphasia Trials by Status
5.4 Average Enrollment in Aphasia Trials by Type of Trial

6. Companies Participating in Aphasia Clinical Trials
6.1 Aphasia Trials by Sponsor Type
6.2 Aphasia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Aphasia Trials- Phase 1
7.2 Aphasia Trials- Phase 2
7.3 Aphasia Trials- Phase 3
7.4 Aphasia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Aphasia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Aphasia Clinical Trials and Enrolment
Figure 5: Europe – Country wise Aphasia Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Aphasia Clinical Trials and Enrolment
Figure 7: North America – Country wise Aphasia Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Aphasia Clinical Trials and Enrolment
Figure 9: Aphasia Clinical Trials by Phase
Figure 10: Aphasia Clinical Trials by Trial Status
Figure 11: Aphasia Clinical Trials by Type
Figure 12: Aphasia Clinical Trials by Sponsor Type
Figure 13: Aphasia Clinical Trials by Leading Sponsors
Figure 14: Aphasia Average Enrollment by Phase
Figure 15: Aphasia Average Enrollment by Trial Status
Figure 16: Aphasia Average Enrollment by Type
Figure 17: Aphasia- Average Enrolment by Type of Sponsors
Figure 18: Aphasia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Aphasia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Aphasia Clinical Trials and Enrolment
Table 5: Europe – Country wise Aphasia Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Aphasia Clinical Trials and Enrolment
Table 7: North America – Country wise Aphasia Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Aphasia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Aphasia Average Enrollment by Phase
Table 15: Aphasia Average Enrollment by Trial Status
Table 16: Aphasia Average Enrollment by Type
Table 17: Aphasia- Average Enrolment by Type of Sponsors
Table 18: Aphasia- Enrolment by Leading Sponsors

Companies mentioned
Axon Neuroscience SE, Berry Consultants LLC, Eisai Co Ltd, Gabinete Berthier y Martinez, Johnson & Johnson, Novastem, Pfizer Inc, Shanxi Zhendong Pharmaceutical Co Ltd, TauRx Pharmaceuticals Ltd, The Lundbeck Foundation